ASHLEY RING: Open Payments
NPI 1336626076 · TIFTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,463 in 83 payments from 14 companies in 2025. Trend: 2023 $953 · 2024 $1,390 · 2025 $1,463
Food & beverage: $1,463
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $323 |
| AstraZeneca Pharmaceuticals LP | 13 | $227 |
| Novo Nordisk Inc | 10 | $167 |
| Lilly USA, LLC | 9 | $161 |
| PFIZER INC. | 6 | $131 |
| GlaxoSmithKline, LLC. | 6 | $90 |
| SHIELD THERAPEUTICS INC | 4 | $87 |
| Dexcom, Inc. | 5 | $86 |
| Medtronic, Inc. | 2 | $55 |
| Sumitomo Pharma America, Inc. | 1 | $44 |
Products named: FARXIGA, UBRELVY, MOUNJARO, TRELEGY ELLIPTA, ACCRUFER, Dexcom G6 Transmitter, Wegovy, VRAYLAR.
Industry payments across GA — which companies pay providers there.
